In renal cancers, activation of autophagy with mTOR inhibitor everolimus shows antitumor effects, whereas combination of chloroquine to block the fusion of autophagosomes and lysosomes potentiates the antitumor effects of everolimus [29]. This evidence concerns the gene MTOR and renal carcinoma.